Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02893761 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Bergonie Institute Breast Cancer Database

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Active, Not Recruiting to Recruitingv3 Show 5 more changesShow less
    • Primary completion date: Jan 2015 to Dec 2030
    • Primary endpoints: 2 to 1
    • Enrollment target: 21439 to 30000
    • Study completion date: Dec 2050
    • Secondary endpoints shortened, about 3 words
  2. Re-verified, no change to tracked fieldsv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Institut Bergonié
40 trials monitored
See 1 trial at risk
Breast Cancer
5,418 trials monitored
See 296 trials at risk
A database of breast cancer patients was established at Institute Bergonié since the 90s , to assess patients' survival, assess practice, search for prognostic factors.
Trial Details
NCT Number NCT02893761
Lead Sponsor Institut Bergonié
Conditions
(from sponsor)		 Breast Cancer
Related terms Breast Neoplasms
Enrollment 30,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov